Cargando…

Intensified therapy in diffuse large B-cell lymphoma

Detalles Bibliográficos
Autores principales:	Novo, Mattia, Castellino, Alessia, Chiappella, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849151/ https://www.ncbi.nlm.nih.gov/pubmed/29560087 http://dx.doi.org/10.18632/oncotarget.23770

Ejemplares similares

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Epigenomic evolution in diffuse large B-cell lymphomas
por: Pan, Heng, et al.
Publicado: (2015)

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
por: Chiappella, Annalisa, et al.
Publicado: (2019)

Antibody Therapies for Large B-Cell Lymphoma
por: Novo, Mattia, et al.
Publicado: (2021)

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma
por: Quintás-Cardama, Alfonso
Publicado: (2018)

Towards genomic-based prognostication and precision therapy for diffuse large B-cell lymphoma
por: Minderman, Marthe, et al.
Publicado: (2020)

Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
por: Bari, Alessia, et al.
Publicado: (2022)

Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma
por: Napoli, Sara, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment
por: Pileri, Stefano A., et al.
Publicado: (2019)

PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA-RB)
por: Novo, M., et al.
Publicado: (2022)

Integration of cell therapies and bispecific antibodies into the treatment pathway of relapsed diffuse large B-cell lymphoma
por: Rampotas, Alexandros, et al.
Publicado: (2021)

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma
por: Nowakowski, Grzegorz S, et al.
Publicado: (2016)

Central nervous system prophylaxis in diffuse large B-cell lymphoma: a race to the bottom
por: Roschewski, Mark
Publicado: (2021)

Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
por: Qiu, Minghan, et al.
Publicado: (2022)

Immune targeted therapy for diffuse large B cell lymphoma
por: Zheng, Yaxin, et al.
Publicado: (2021)

Preventing central nervous system spread in diffuse large B-cell lymphoma – novel approaches needed
por: Roschewski, Mark
Publicado: (2021)

Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
por: Jeon, Youngwoo
Publicado: (2023)

New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
por: Arcari, Annalisa, et al.
Publicado: (2023)

P1217: INTRATHECAL METHOTREXATE PROPHYLAXIS AND CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH INTENSIFIED R-ACVBP STRATEGY
por: Renaud, L., et al.
Publicado: (2022)

Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma
por: Pasqualucci, Laura, et al.
Publicado: (2011)

Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
por: Harris, Leonard Jeff, et al.
Publicado: (2020)

Diffuse large B-cell lymphoma: new targets and novel therapies
por: Cheson, Bruce D., et al.
Publicado: (2021)

Evolution of therapy for limited stage diffuse large B-cell lymphoma
por: Rojek, Alexandra E., et al.
Publicado: (2022)

Development of combinatorial antibody therapies for diffuse large B cell lymphoma
por: Geanes, Eric S., et al.
Publicado: (2022)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma?
por: Park, Sang-Gon
Publicado: (2019)

CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
por: Hopfinger, Georg, et al.
Publicado: (2019)

Inflammatory Cells in Diffuse Large B Cell Lymphoma
por: Tamma, Roberto, et al.
Publicado: (2020)

PI3K/AKT addiction in subsets of diffuse large B-cell lymphoma
por: Pfeifer, Matthias, et al.
Publicado: (2013)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Gupta, Varsha, et al.
Publicado: (2022)

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome
por: Ohya, Eiko, et al.
Publicado: (2016)

Network meta-analysis of targeted therapies for diffuse large B cell lymphoma
por: Wang, Jie, et al.
Publicado: (2020)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
por: González-Rincón, Julia, et al.
Publicado: (2019)

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma
por: Fan, Kenneth C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_li0pu3h178962bgejj56stnn02